Skip to content

The European Union Falsified Medicines Directive (FMD) is designed to protect public health by securing the pharmaceutical supply chain against counterfeit medicines. It’s a rigorous set of rules that pharmaceutical companies operating in Europe need to abide by, and at Sharp we can help.

Our comprehensive serialisation service can help you meet the criteria demanded by the FMD by making your products fully traceable and trackable through their supply chain.

We’re able to aggregate serial numbers for up to five levels of packaging in multiple formats, from the cavities of our blister packs through to the pallets they ship in, so you’ll always be able to identify where your products are – and where they came from.

Related Resources

Today we celebrate the life and achievements of Dr. Martin Luther King Jr., influential American civil rights leader whose work to promote equal rights, regardless of background, changed history. #MLKDay

One size does not fit all. This is why Sharp has developed a suite of flexible, scalable and efficient clinical trial management solutions including Clinteract IRT and Clinventory IMS.

Contact us today to schedule a demo: https://lnkd.in/ekUQmFH

#clinicalIRT

Sharp’s analytical chemists offer a variety of photostability studies for your drug substance or product.

Contact us today to discover how our specialist solutions can improve your #clinicaltrial processes: https://www.sharpservices.com/our-services/clinical/

#drugdevelopment #clinicalservices